GRANULOCYTE-COLONY-STIMULATING FACTOR DOWN-REGULATES ALLOGENEIC IMMUNE-RESPONSES BY POSTTRANSCRIPTIONAL INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
A. Kitabayashi et al., GRANULOCYTE-COLONY-STIMULATING FACTOR DOWN-REGULATES ALLOGENEIC IMMUNE-RESPONSES BY POSTTRANSCRIPTIONAL INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION, Blood, 86(6), 1995, pp. 2220-2227
We report downregulatory effects of granulocyte colony-stimulating fac
tor (G-CSF) on allogeneic immune responses in vitro. G-CSF did not aff
ect the proliferative response of peripheral blood mononuclear cells (
PBMC) against allogeneic Daudi cells but did inhibit tumor necrosis fa
ctor (TNF)-alpha secretion. In contrast with G-CSF, granulocyte-macrop
hage (GM)-CSF and interleukin (IL)-3 enhanced alloactivation-induced T
NF-alpha production. G-CSF-mediated suppression of TNF-alpha productio
n was not affected by fixation of stimulators. G-CSF did not inhibit T
NF-alpha mRNA expression or accelerate mRNA degradation, whereas pento
xifylline inhibited the expression of TNF-alpha mRNA. These results in
dicate that G-CSF acts directly on responder cells and modulates TNF-a
lpha production at posttranscriptional levels. Suppression of TNF-alph
a secretion was accompanied by an increase of intracellular cyclic ade
nosine monophosphate (cAMP) concentration in alloactivated PBMC. The c
ell permeable cAMP analogue, dibutyryl cAMP, suppressed TNF-alpha secr
etion without affecting TNF-alpha mRNA expression, G-CSF showed an inh
ibitory effect on the development of cytotoxic effector cells against
allogeneic Daudi cells. Anti-TNF-alpha monoclonal antibody (MoAb) also
inhibited the induction of cytolytic activity, and the inhibitory eff
ects of G-CSF and anti-TNF-alpha MoAb on killer activity generation we
re overcome by adding exogenous TNF-alpha. Hence, impaired generation
of cytolytic effector cells by G-CSF is believed to be the result of r
educed TNF-alpha production, Collectively, the results described above
suggest that G-CSF downregulates allogeneic immune responses by postt
ranscriptionally inhibiting TNF-alpha production. (C) 1995 by The Amer
ican Society of Hematology.